New Strategies for Multiple Myeloma Care: Case Studies for Nurses

Part 1: Newly Diagnosed Multiple Myeloma
CNE

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN;
Joseph D. Tariman, PhD, RN, ANP-BC, FAAN    
Release Date: August 18, 2020
Expiration Date: August 18, 2021

This activity on newly diagnosed multiple myeloma will include an overview of the disease, as well as current treatment workup and testing recommendations for multiple myeloma. Through the cases of June and Lisa, our faculty will explore transplant eligibility, induction, and maintenance therapy. Please remember to complete part 2 and 3 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey.

Download Slides

Begin, Earn Credit   View Only, No Credit

Part 2: Relapsed Multiple Myeloma
CNE

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN;
Amy E. Pierre, RN, MSN, ANP-BC   
Release Date: August 18, 2020
Expiration Date: August 18, 2021

This activity on relapsed multiple myeloma will include some recently approved drugs and dosage forms. Through the cases of Steve and Michelle, our faculty will review treatment considerations in the cases of early relapsed patients. Please remember to complete part 1 and 3 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey.

Download Slides

Begin, Earn Credit   View Only, No Credit

Part 3: Heavily Pretreated Multiple Myeloma and Drugs in Development
CNE

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN;
Tiffany Richards, PhD, ANP-BC, AOCNP® 
Release Date: August 18, 2020
Expiration Date: August 18, 2021

This activity will focus on heavily pretreated multiple myeloma and drugs in development. Through the case of Carl, a patient who has received several multiple myeloma therapies over his 10-year history with the disease, our faculty will discuss clinical trial participation, and drugs in development. Please remember to complete part 1 and 2 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey.

Download Slides

Begin, Earn Credit   View Only, No Credit